|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2002-4-25
|
|
pubmed:abstractText |
Carboplatin and paclitaxel can be applied safely and effectively as single agents for the treatment of ovarian cancer on a weekly basis. A multicenter, phase-I study was conducted to investigate the maximum tolerated dose of a weekly combination regimen.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0090-8258
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2002 Elsevier Science (USA).
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
85
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
321-6
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:11972395-Adult,
pubmed-meshheading:11972395-Aged,
pubmed-meshheading:11972395-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11972395-Carboplatin,
pubmed-meshheading:11972395-Dose-Response Relationship, Drug,
pubmed-meshheading:11972395-Drug Administration Schedule,
pubmed-meshheading:11972395-Female,
pubmed-meshheading:11972395-Humans,
pubmed-meshheading:11972395-Middle Aged,
pubmed-meshheading:11972395-Neoplasm Staging,
pubmed-meshheading:11972395-Ovarian Neoplasms,
pubmed-meshheading:11972395-Paclitaxel
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
First-line chemotherapy with weekly paclitaxel and carboplatin for advanced ovarian cancer: a phase I study.
|
|
pubmed:affiliation |
Department of Gynecology and Obstetrics, Charité Virchow University Hospital, Augustenberger Platz 1, 13353 Berlin, Germany. sehouli@aol.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase I
|
